4.7 Article

Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure

W. H. Wilson Tang et al.

CIRCULATION-HEART FAILURE (2011)

Article Medicine, Research & Experimental

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

Christian Besler et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Multidisciplinary Sciences

Progress and challenges in translating the biology of atherosclerosis

Peter Libby et al.

NATURE (2011)

Review Biochemistry & Molecular Biology

The roles of PON1 and PON2 in cardiovascular disease and innate immunity

Diana M. Shih et al.

CURRENT OPINION IN LIPIDOLOGY (2009)

Article Medicine, General & Internal

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

Tamali Bhattacharyya et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Genetics & Heredity

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

Cristen J. Willer et al.

NATURE GENETICS (2008)

Article Biotechnology & Applied Microbiology

Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin

Sara Deakin et al.

PHARMACOGENETICS AND GENOMICS (2007)

Article Cardiac & Cardiovascular Systems

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

A Tward et al.

CIRCULATION (2002)